N/A N=28 Randomized Single-blind Treatment

Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession

Gingival Recession

Bottom Line

View on ClinicalTrials.gov: NCT03199118 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2021

Primary outcome: Primary: Recession Depth — 2; 2; 0; 0 length in millimeters

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: CAF +SCTG (Procedure); platelet rich fibrin (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Cairo University
Primary completion: Dec 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Recession Depth	2; 2; 0; 0; 0; 0	—
SECONDARY Recession Width	1.5; 2; 0; 0; 0; 0	—
SECONDARY Root Coverage Gain	92.9; 91.6	—
SECONDARY Probing Depth	1.71; 1.5; 1.07; 1.07; 1.07; 1.21	—
SECONDARY Clinical Attachment Level	3.79; 4; 2.14; 2.29; 2; 2.07	—
SECONDARY Gingival Biotype	1; 1; 3; 2.5; 3; 3	—
SECONDARY Width of Keratinized Gingiva	2.36; 2.64; 3.64; 3.71; 3.86; 4.14	—
SECONDARY Patient Satisfaction	71.4; 64.3	—
SECONDARY Root Coverage Esthetic Score (RES)	9.43; 9.29	—
SECONDARY Post Operative Pain	9; 8.5	—

Summary

This research will be conducted in an attempt to achieve complete root coverage with physiologic probing depth and a harmonious view with the adjacent tissues using Platelet rich fibrin in conjunction with Coronally advanced flap and subepithelial connective tissue graft.

Eligibility Criteria

Inclusion Criteria

1) Patients 18 years and older 2) Buccal recession defects classified as either Miller class I or II gingival recession.
Clinical indication and/or patient request for recession coverage 4) Good oral hygiene

Exclusion Criteria

1) Miller Class III and IV gingival recession. 2) Any systemic diseases or any medication. 3) Pregnancy. 4) Patients undergoing radiotherapy. 5) Handicapped and mentally retarded patients. 6) Current and former smokers as smoking is a contra-indication for plastic periodontal surgery .
Teeth with cervical restorations, abrasion

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03199118). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.